15th February 2022 | Pharma Updates
Manufacturing Licenses of Two Drug Firms Suspended In Himachal
HP’s Excise and Taxation Department has suspended the manufacturing licenses of two pharma companies situated near Sirmaur for violating provisions of the Narcotic Drugs and Psychotropic Substances Act and unusual sales.
CDSCO Flags 27 Drugs
Central Drugs Standard Control Organization checked 1227 drug samples, out of which 27 were not of standard quality.
Paxlovid Receives Conditional Approval In China
The drugmaker is in conversation with over 100 nations and can provide 120 mn courses of Paxlovid if required.
Senseonics to Market E3 CGM System
The Glucose Monitoring System can be used for up to 6 months, available to patients of United States of America, during the second quarter of this year.
Minnetronix Signs a Pact with INO
Minnetronix Medical, a US-based medical device technology partner, and INO Innovation Center have inked an agreement to bring optical medical devices.
Fifth Eye in Ann Arbor Gets US FDA Clearance for Medical Monitoring System
The US Food and Drug Administration has granted approval to market the AHI system to hospitals in USA.
Israel to Introduce Pill for Covid Patients with Serious Complications
AstraZeneca’s Evusheld is expected to arrive in Israel within a few days.
Collegium Pharmaceutical to buy BioDelivery Sciences
The drug company will acquire BioDelivery Sciences for USD 5.60/share in an all-cash deal.
Armenia buys over 100K doses of Pfizer Covid Vaccine
The drug major has imported around 100620 Covid vaccines to Armenia.
Cerenovus Invests EUR 50 mn In Galway
Cerenovus is all set to create 30 specialized jobs by setting up a manufacturing plant in Galway.
